You are here

Allergan

Sandoz to pay Allergan, Duke University $39M over eye drug lawsuit, jury says

Endpoints

Mon, 04/3/23 - 10:46 pm

Duke University

Allergan’s DREAM initiative partners with Shutterstock to promote racial equity in aesthetics

Medical Marketing and Media

Sun, 12/11/22 - 01:25 pm

pharma marketing

DREAM initiative

Teva, AbbVie's Allergan lock in $6.6B deal to settle thousands of US opioid lawsuits

Fierce Pharma

Sat, 11/26/22 - 07:11 pm

Teva Pharmaceutical

AbbVie inks $54M settlement to resolve Namenda 'pay-for-delay' lawsuit

Fierce Pharma

Tue, 11/15/22 - 06:37 pm

Alzheimer's disease

AbbVie unveils 'See Yourself' Botox campaign, days after new rival approved

Endpoints

Tue, 09/13/22 - 08:06 pm

Revance Therapeutics

AbbVie fends off patent claim in unusual whistleblower case

Fierce Pharma

Fri, 08/26/22 - 12:18 pm

whistleblower lawsuits

Alzheimer's disease

Teva, AbbVie ink $58M opioid settlement to resolve San Francisco claims

Fierce Pharma

Wed, 07/13/22 - 10:39 am

Teva Pharmaceutical

AbbVie Inks Licensing Agreement To Use Sirona Biochem's New Skincare Technology

CP WIre

Mon, 06/13/22 - 12:54 pm

AbbVie Inks Licensing Agreement To Use Sirona Biochem's New Skincare Technology

Mon, 06/13/22 - 12:52 pm

Teva, AbbVie's Allergan hand over $161M to settle opioid lawsuit in West Virginia

Fierce Pharma

Wed, 05/25/22 - 11:36 pm

Teva Pharmaceutical

AbbVie, Teva looking to settle nationwide opioid litigation for $5B+: Bloomberg

Fierce Pharma

Wed, 05/11/22 - 11:05 pm

Teva Pharmaceutical

AbbVie's Q1 Good News That Investors Could Be Missing

Motley Fool

Sat, 04/30/22 - 02:31 pm

Rhode Island reaches $28.5-million in settlements with opioid manufacturers

The Providence Journal, RI

Mon, 03/21/22 - 10:25 pm

Teva Pharmaceutical

Teva, Endo and more back on the hook in San Francisco opioid trial

Fierce Pharma

Thu, 02/24/22 - 11:00 pm

Teva Pharmaceutical

Endo International

AbbVie sees a megablockbuster in Vraylar. Could a new depression indication push peak sales past $4B?

Endpoints

Wed, 02/23/22 - 10:24 pm

major depressive disorder

AbbVie notches reprieve in antitrust case involving blood pressure med snagged in $63B Allergan megamerger

Fierce Pharma

Wed, 01/26/22 - 11:00 am

FDA restricts breast implant sales, cites Allergan and J&J for inadequate postapproval progress

Medtech Dive

Fri, 10/29/21 - 10:39 am

breast implants

AbbVie closes in on Biohaven with new migraine prevention OK for oral CGRP drug

Endpoints

Wed, 09/29/21 - 11:04 am

AbbVie hands back headline drug in $63B Allergan buyout to Molecular Partners after FDA rejection. What's next?

Endpoints

Mon, 08/9/21 - 11:54 pm

Molecular Partners

Drugs facing the most patent expirations this year

Drug Patent Watch

Sun, 08/1/21 - 11:46 pm

Gilead Sciences

Pages